Physician profile
Sarah Howe
NPI 1811596745
$4,852.85
in general payments reported to CMS, 2019-2025
12 companies · $937 in 2025
The $937 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.19 · 2022: $1,285 · 2023: $220 · 2024: $2,377 · 2025: $937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,033 · Travel and Lodging: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,033.13 |
| Travel and Lodging | $1,500.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $2,024.08 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $1,143.45 | 2022-2025 | Acticoat 4" X 4", Pico, Allevyn Gentle Border 10 X 10cm Ctn 10 |
| Medtronic, INC. | $1,130.14 | 2022-2025 | Venaseal |
| Paratek Pharmaceuticals, INC. | $148.14 | 2022 | |
| Boston Scientific Corporation | $120.38 | 2022-2025 | Varithena Administration Pack |
| Tactile Systems Technology INC | $89.18 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Convatec INC. | $58.74 | 2024-2025 | |
| Nevro Corp. | $51.98 | 2024 | Senza |
| Organogenesis INC. | $34.19 | 2021 | |
| Janssen Pharmaceuticals, INC | $21.19 | 2022 | |
| Urgo Medical North America, LLC | $17.39 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Cashflow Solutions, LLC | $13.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Howe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.